LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical ModelsNathan A. Brooks, Raymond Gilmour, Vivian Salama et al.|Blood Cancer Discovery|2026Cited by 0